Q4 earnings shaping up to be the best of 2023

Traders work on the floor at the New York Stock Exchange on Feb. 1, 2024. Brendan McDermid | Reuters Here’s how big of a surprise corporate profits have been this earnings season: The fourth quarter is now shaping up to be the best of 2023. Despite ongoing macroeconomic concerns that have hampered demand and weighed … Read more

Follow CEOs at the JPMorgan Healthcare Conference

CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan’s market-moving health-care conference in San Francisco. Taking place from Monday to Thursday, the conference is one of the year’s largest gatherings of major industry CEOs where they reveal earnings guidance and updates on clinical trial research. “The … Read more

Bristol Myers Squibb to buy Karuna Therapeutics

Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock popped more than 47% on the news Friday morning, hitting around $317 a share. Bristol Myers Squibb shares rose more than 2%. The deal will help expand Bristol Myers’ drug … Read more